Interleukin-6: A Masterplayer in the Cytokine Network von Uciechowski, Peter, Dempke, Wolfram C.M.

Volltext

Targeting SHP-1, 2 and SHIP Pathways: A Novel Strategy for Cancer Treatment? von Dempke, Wolfram C.M., Uciechowski, Peter, Fenchel, Klaus, Chevassut, Timothy

Volltext

Targeted therapies for non-small cell lung cancer von Dempke, Wolfram C.M, Suto, Tamas, Reck, Martin

Volltext

Targeting Developmental Pathways: The Achilles Heel of Cancer? von Dempke, Wolfram C.M., Fenchel, Klaus, Uciechowski, Peter, Chevassut, Timothy

Volltext

Anthracycline-induced cardiotoxicity — are we about to clear this hurdle? von Dempke, Wolfram C.M., Zielinski, Rafal, Winkler, Christina, Silberman, Sandra, Reuther, Susanne, Priebe, Waldemar

Volltext

KEAP1/NRF2 (NFE2L2) mutations in NSCLC – Fuel for a superresistant phenotype? von Dempke, Wolfram C.M., Reck, Martin

Volltext

Targeting the undruggable: menin inhibitors ante portas von Dempke, Wolfram C. M., Desole, Maximilian, Chiusolo, Patrizia, Sica, Simona, Schmidt-Hieber, Martin

Volltext

Brain Metastases in NSCLC - are TKIs Changing the Treatment Strategy? von Dempke, Wolfram C M, Edvardsen, Klaus, Lu, Shun, Reinmuth, Niels, Reck, Martin, Inoue, Akira

Volltext

Efficacy and Safety of Approved First-Line Tyrosine Kinase Inhibitor Treatments in Metastatic Renal Cell Carcinoma: A Network Meta-Analysis von Manz, Kirsi M., Fenchel, Klaus, Eilers, Andreas, Morgan, Jonathan, Wittling, Kirsten, Dempke, Wolfram C. M.

Volltext

Immunotherapies for NSCLC: Are We Cutting the Gordian Helix? von Dempke, Wolfram C M, Sellmann, Ludger, Fenchel, Klaus, Edvardsen, Klaus

Volltext

Expert consensus on neoadjuvant immunotherapy for non-small cell lung cancer von Liang, Wenhua, Cai, Kaican, Chen, Chun, Chen, Haiquan, Chen, Qixun, Fu, Junke, Hu, Jian, Jiang, Tao, Jiao, Wenjie, Li, Shuben, Liu, Changhong, Liu, Deruo, Liu, Wei, Liu, Yang, Ma, Haitao, Pan, Xiaojie, Qiao, Guibin, Tian, Hui, Wei, Li, Zhang, Yi, Zhao, Song, Zhao, Xiaojing, Zhou, Chengzhi, Zhu, Yuming, Zhong, Ran, Li, Feng, Rosell, Rafael, Provencio, Mariano, Massarelli, Erminia, Antonoff, Mara B., Hida, Toyoaki, de Perrot, Marc, Lin, Steven H., Di Maio, Massimo, Rossi, Antonio, De Ruysscher, Dirk, Ramirez, Robert A., Dempke, Wolfram C. M., Camidge, D. Ross, Guibert, Nicolas, Califano, Raffaele, Wang, Qi, Ren, Shengxiang, Zhou, Caicun, He, Jianxing

Volltext

BCKDK alters the metabolism of non-small cell lung cancer von Wang, Yanhui, Xiao, Jiawei, Jiang, Wenna, Zuo, Duo, Wang, Xia, Jin, Yu, Qiao, Lu, An, Haohua, Yang, Lexin, Dumoulin, Daphne W., Dempke, Wolfram C. M., Best, Sarah A., Ren, Li

Volltext

Durvalumab plus novel agents in non-small cell lung cancer—a new COAST on the horizon? von Dempke, Wolfram C. M., Fenchel, Klaus, Reuther, Susanne, Murphy, Michael F.

Volltext

Ras Mutational Status Is a Biomarker for Resistance to EGFR Inhibitors in Colorectal Carcinoma von DEMPKE, Wolfram C. M, HEINEMANN, Volker

Volltext

Improved overall survival following tyrosine kinase inhibitor treatment in advanced or metastatic non-small-cell lung cancer—the Holy Grail in cancer treatment? von Sellmann, Ludger, Fenchel, Klaus, Dempke, Wolfram C. M.

Volltext

International expert consensus on immunotherapy for early-stage non-small cell lung cancer von Liang, Wenhua, Cai, Kaican, Cao, Qingdong, Chen, Chun, Chen, Haiquan, Chen, Jun, Chen, Ke-Neng, Chen, Qixun, Chu, Tianqing, Dong, Yuchao, Fan, Jiang, Fang, Wentao, Fu, Junke, Fu, Xiangning, Gao, Shugeng, Ge, Di, Geng, Guojun, Geng, Qing, He, Jie, Hu, Jian, Hu, Jie, Hu, Wei-Dong, Jiang, Feng, Jiang, Tao, Jiao, Wenjie, Li, He-Cheng, Li, Qiang, Li, Shanqing, Li, Shuben, Li, Xiangnan, Liao, Yong-De, Liu, Changhong, Liu, Hongxu, Liu, Yang, Lu, Zhuming, Luo, Qingquan, Ma, Haitao, Pan, Xiaojie, Qiao, Guibin, Ren, Shengxiang, Shen, Weiyu, Song, Yong, Sun, Daqiang, Wang, Guangsuo, Wang, Jie, Wang, Mengzhao, Wang, Qiwen, Wang, Wen-Xiang, Wei, Li, Wu, Ming, Wu, Nan, Xia, Hui, Xu, Shi-Dong, Yang, Fan, Yang, Kang, Yang, Yue, Yu, Fenglei, Yu, Zhen-Tao, Yue, Dong-Sheng, Zhang, Lanjun, Zhang, Weidong, Zhang, Zhenfa, Zhao, Guofang, Zhao, Jian, Zhao, Xiaojing, Zhou, Chengzhi, Zhou, Qinghua, Zhu, Kunshou, Zhu, Yuming, Hida, Toyoaki, Dempke, Wolfram C. M., Rossi, Antonio, Perrot, Marc de, Ramirez, Robert A., Provencio, Mariano, Lee, Jay M., Passaro, Antonio, Spaggiari, Lorenzo, Spicer, Jonathan, Girard, Nicolas, Forde, Patrick M., Mok, Tony S. K., Cascone, Tina, He, Jianxing

Volltext

Multiple Myeloma: Myeloablative Therapy with Autologous Stem Cell Support versus Chemotherapy: A Meta-analysis von FAUSSNER, Florian, DEMPKE, Wolfram C. M

Volltext

Improved overall survival following tyrosine kinase inhibitor (TKI) treatment in NSCLC—are we making progress? von Fenchel, Klaus, Dale, Stephen P., Dempke, Wolfram C. M.

Volltext

An early Phase II study of intratumoral P‐32 chromic phosphate injection therapy for patients with refractory solid tumors and solitary metastases von Firusian, Nosrat, Dempke, Wolfram

Volltext

Differential expression of drug resistance following in vitro exposure of human tumour cell lines to fractionated X-irradiation von Hill, Bridget T., Whelan, Richard D.H., Hosking, Louise K., Bedford, Philip, Dempke, Wolfram C.M., Shellard, Sharon A.

Volltext